Episode

Episode 57. ASH 2024 Update on Leukemia/Myeloid Neoplasms with Dr. Jayastu Senapati

Podcast
Blood Cancer Talks
Published
Mar 19, 2025
Duration seconds
3324
Processing state
not_requested
Canonical source
https://share.transistor.fm/s/c1cbf2f9
Audio
https://media.transistor.fm/c1cbf2f9/02e4d9f1.mp3
JSON
/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-57-ash-2024-update-on-leukemia-myeloid-neoplasms-with-dr-jayastu-senapati
Markdown
/podcast/blood-cancer-talks-5570002/episode-57-ash-2024-update-on-leukemia-myeloid-neoplasms-with-dr-jayastu-senapati.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-57-ash-2024-update-on-leukemia-myeloid-neoplasms-with-dr-jayastu-senapati/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/blood-cancer-talks-5570002/episode-57-ash-2024-update-on-leukemia-myeloid-neoplasms-with-dr-jayastu-senapati.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, we delve into the key clinically relevant abstracts in leukemia and myeloid neoplasms with Dr. Jayastu Senapati from the MD Anderson Cancer Center. Here are the links to the abstracts we discussed: Older AML: Ven+HMA vs 7+3 Abstract 450: https://ash.confex.com/ash/2024/webprogram/Paper210320.html Abstract 971: https://ash.confex.com/ash/2024/webprogram/Paper202801.html Abstract 969: https://ash.confex.com/ash/2024/webprogram/Paper199267.html Venetoclax resistance mechanisms https://pubmed.ncbi.nlm.nih.gov/39478230/ FLAG-GO vs FLAG-IDA https://ashpublications.org/blood/article/144/Supplement%201/1513/532742/Gemtuzumab-Ozogamicin-Added-to-Fludarabine CPX-351: Abstract 55: https://ash.confex.com/ash/2024/webprogram/Paper207094.html Abstract 60: https://ash.confex.com/ash/2024/webprogram/Paper200413.html Menin Inhibitors Abstract 211 https://ash.confex.com/ash/2024/webprogram/Paper194384.html Abstract 212 https://ash.confex.com/ash/2024/webprogram/Paper207106.html Abstract 213 https://ash.confex.com/ash/2024/webprogram/Paper194827.html Abstracts 214 https://ash.confex.com/ash/2024/webprogram/Paper198218.html Abstract 215 https://ash.confex.com/ash/2024/webprogram/Paper198218.html Abstract 216 https://ash.confex.com/ash/2024/webprogram/Paper204375.html FLT3 inhibitors Abstract 221: https://ash.confex.com/ash/2024/webprogram/Paper201595.html MDS Abstract 349: https://ash.confex.com/ash/2024/webprogram/Paper194510.html ATRA in MDS: https://ash.confex.com/ash/2024/webprogram/Paper200433.html